GlassScriptPhysician profile
Andrew C Olsen
NPI 1053873950
$1,032.62
in general payments reported to CMS, 2019-2025
11 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.57 · 2023: $252 · 2024: $205 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $245.61 | 2024-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $244.06 | 2023-2024 | |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $113.02 | 2023 | Senza |
| Stryker Corporation | $97.57 | 2022 | |
| Globus Medical, INC. | $56.99 | 2025 | Senza |
| Nexus Medical Technologies LLC | $46.22 | 2025 | |
| Medtronic, INC. | $27.79 | 2025 | Inceptiv |
| Mml US, INC. | $26.51 | 2025 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $19.09 | 2025 | |
| Si-Bone, INC. | $14.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.